Mark Gergen

Mark Gergen

Chairman presso POSEIDA THERAPEUTICS, INC.

Patrimonio netto: 2 M $ in data 31/03/2024

61 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Mark J.
Gergen
is currently the Executive Chairman at Poseida Therapeutics, Inc. and an Independent Director at Aristea Therapeutics, Inc. He previously worked as a Director at Aperio Technologies, Inc., Chief Financial & Development Officer at Advanced Tissue Sciences, Inc., Senior Vice President-Corporate Development at Amylin Pharmaceuticals, Inc., Principal at Jostens, Inc., Principal at Medtronic, Inc., Chief Operating Officer & Senior Vice President at Halozyme Therapeutics, Inc., Executive Vice President at CardioNet LLC, Principal at Premier Healthcare Solutions, Inc., and Chief Operating Officer, Secretary & Executive VP at Mirati Therapeutics, Inc. Mr. Gergen obtained his undergraduate degree from Minot State University and his graduate degree from The University of Minnesota Law School.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
01/03/2024 651 291 ( 0.67% ) 2 M $ 31/03/2024

Posizioni attive di Mark Gergen

SocietàPosizioneInizio
POSEIDA THERAPEUTICS, INC. Chairman 01/02/2023
Director/Board Member 24/08/2022
Tutte le posizioni attive di Mark Gergen

Precedenti posizioni note di Mark Gergen

SocietàPosizioneFine
HALOZYME THERAPEUTICS, INC. Chief Operating Officer 29/09/2017
MIRATI THERAPEUTICS Chief Operating Officer 16/09/2016
Corporate Officer/Principal 01/11/2012
Corporate Officer/Principal 01/03/2005
Advanced Tissue Sciences, Inc. Director of Finance/CFO -
Vedi nel dettaglio l'esperienza di Mark Gergen

Formazione di Mark Gergen

Minot State University Undergraduate Degree
The University of Minnesota Law School Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Mark Gergen

Relazioni

100 +

Relazioni di 1° grado

13

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
HALOZYME THERAPEUTICS, INC.

Health Technology

POSEIDA THERAPEUTICS, INC.

Health Technology

Aziende private9
Advanced Tissue Sciences, Inc.

Commercial Services

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Vedi le connessioni aziendali